ON THE PEN RESOURCES AND LINKS: HTTPS://WWW.OTPLINKS.COM What if the most powerful obesity drug ever created ends up being the one you can’t get? That’s the real conversation around retatrutide right now. In this video, I break down what Eli Lilly is doing behind the scenes, and why this isn’t just about whether retatrutide is better than tirzepatide. This is about strategy. This is about access. And this is about who gets left behind. We’re talking about: • The push to classify retatrutide as a biologic • Why that could mean pricing in the $7,000/month range • How LillyDirect is changing access to tirzepatide • The “two lane” system that could define obesity treatment going forward • And what this means for patients already struggling to stay on GLP-1 therapies If you’ve ever fought insurance, dealt with compounding disappearing, or felt like the system decides what you’re allowed to have… this one is for you. 👇 Let’s talk about it Have you ever felt stuck between “this is working” and “this isn’t enough”… with no clear path forward?

Retatrutide Could Change Everything… But Who Actually Gets It?

On The Pen GLP-1 News

# Full Transcript

**Podcast:** On The Pen GLP-1 News

## Transcript

What If I Told You That Retatrutide, The Most Powerful Metabolic Modulating Drug Ever Created, Might Also Be The Hardest Obesity Medicine Ever To Access? I Think That Is Exactly What Eli Lilly Is Shaping Up By Design Because The Last Thing They Want To Do Is Cannibalize Terzepatide Scrips With Retatrutide Scrips. And The Gray Market Just May Have Given Them Their Template. We're Going To Get Into All That And More On Today's Episode Of The Weekly Dose Podcast.

This Is One You're Not Going To Want To Miss. So Stay Tuned And Buckle Up. Welcome To The On The Pen Podcast With Your Host Dave Knapp. Welcome Back To The Weekly Dose Podcast. I'm Your Host Dave Knapp, Man On The Majora. That's Why I'm Here.

You Are On The Pen. We Gove, Saxenda, Victosa, Trulicity, Majora, Zepbound, That Pen, Or Pill. We Gove, Foundeo. It's What We Talk About Each And Every Week Because We Share You All The News And Information Around These Medications That Empowers You To Have More Competent And Confident Conversations With Your Doctor. And If That Sounds Like Something That Might Help You On Your Journey, You Need To Pause Right Now And You Need To Subscribe Wherever You're Listening. Spotify, YouTube, Subscribe Because We Drop New Podcasts Every Tuesday. We're Now Two And A Half Years Into This Podcast.

And We Drop Live Episodes Every Monday, Wednesday, Friday At 11 A.M. Central, 12 P.M. Eastern. You Don't Want To Miss Those. Now If You're New To Obesity Medicine, You're Just Dropping In And You're Like, What Even Is This? And You've Actually Talked To Your Doctor About Obesity Medicine And They've Just Kind Of Shut You Out. Look No Further Than Our Partners At Shed. Because Shed Is A Company That Intrinsically Understands The Chronic Relapsing And Multifactorial Disease Of Obesity. And They're Going To Connect You With A Licensed Provider Who Can Tell You What Your Options Are For Treatment.

And The Best Part Is As A Listener Of On The Pen, You're Going To Save 25% With Code OTP25 On Your Obesity Treatment There. So Whatever Your Needs Are, They're Going To Have The Right Solution For You And They're Going To Help You Find It. And I Highly Recommend Our Friends At Shed. Visit TryShed.com And Thank Them For Being A Sponsor Of This Podcast. Now We've Got A Very Interesting Podcast For You Today. One That I've Teased For A Couple Days Here Because I Believe That I've Put Together

A Pretty Good Summary Of Where I Believe Lily Is Headed With Their Strategy As It Relates To Their Go-To-Market For Eli Lily's Red Hat True Tide. Now Red Hat True Tide Is A Drug That We've Been Talking About Literally For Three Years On This Show. We Were Talking About It On This YouTube Channel Before The Internet Had Even Heard Of Red Hat True Tide. And Now It's As Common As Any Other GLP One When You Scroll Through Your Social Media Feed. But What I Think Is Shaping Up Here Is Pretty Massive.

And If You're Somebody Who...

Retatrutide Could Change Everything… But Who Actually Gets It?

Transcript

Built for investment professionals

Every day you wait, your competitors are finding
edge in conversations you're not hearing.

Retatrutide Could Change Everything… But Who Actually Gets It?

Transcript

Built for investment professionals

Every day you wait, your competitors are findingedge in conversations you're not hearing.

Every day you wait, your competitors are finding
edge in conversations you're not hearing.